Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New model of Parkinson's disease created with proteasome inhibitor injection

Oct. 23, 2013

Antibody DCBPR-01101 targets globo H for breast cancer treatment

Oct. 23, 2013

Pfizer's IMA-638 does not meet endpoints in phase IIa trial

Oct. 23, 2013

Phase I data presented on TRAP-based radiopharmaceutical

Oct. 22, 2013

MEDI-3379 inhibits tumor growth in trastuzumab-resistant breast cancer models

Oct. 22, 2013

mGlu2 positive allosteric modulator LY-2607540 chosen for clinical development

Oct. 22, 2013

TaiGen Biotechnologies describes discovery of pan-genotypic HCV NS3/4A protease inhibitors

Oct. 22, 2013

AbbVie details activity of antibody-drug conjugate ABT-414

Oct. 21, 2013

Novel LSD1 inhibitors display good pharmacological properties

Oct. 21, 2013

Multikinase inhibitor DCB-R0237 shows promise in vivo

Oct. 21, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026